Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Vomiting 6Postoperative Nausea and Vomiting 3Neoplasms 3Prostatic Neoplasms 1Pain, Postoperative 1Ovarian Neoplasms 1Nausea 1Myofibroma 1Lung Neoplasms 1Hematologic Neoplasms 1Colonic Neoplasms 1Agnosia 1Adenomyosis 1

Interventions

Carboplatin 156Paclitaxel 154Bevacizumab 96Cyclophosphamide 61Gemcitabine 46olaparib 45Cisplatin 45Topotecan 44niraparib 40liposomal doxorubicin 40pembrolizumab 38Surveys and Questionnaires 33Filgrastim 31Hyperthermic Intraperitoneal Chemotherapy 29Docetaxel 27Taxes 25Blood Specimen Collection 24fludarabine 23Drug Therapy 23Cytoreduction Surgical Procedures 23Peripheral Blood Stem Cell Transplantation 21Etoposide 21Doxorubicin 21Magnetic Resonance Spectroscopy 20durvalumab 17Specimen Handling 17Albumin-Bound Paclitaxel 17Immunoglobulin G 15Disulfides 15Letrozole 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Ovarian Neoplasms × ramosetron × Clear all
NCT02011659 2013-12-13

PONV

National Health Insurance Service Ilsan Hospital

Phase 3 Unknown
128 enrolled
Gynecologic

Ovarian Neoplasms, Vomiting, Postoperative Nausea and Vomiting, Myofibroma, Adenomyosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡